- £198.76m
- £265.39m
- £163.15m
- 61
- 32
- 73
- 57
Annual income statement for Redcentric, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 87.5 | 91.4 | 93.3 | 142 | 163 |
| Cost of Revenue | |||||
| Gross Profit | 55.2 | 57.9 | 59.5 | 101 | 118 |
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 96.2 | 78.6 | 86.7 | 151 | 162 |
| Operating Profit | -8.74 | 12.8 | 6.61 | -8.94 | 0.852 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -10.6 | 11.3 | 5.54 | -12.5 | -4.65 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -10.6 | 9.01 | 6.94 | -9.25 | -3.44 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -10.6 | 9.01 | 6.94 | -9.25 | -3.44 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -10.6 | 9.01 | 6.94 | -9.25 | -3.44 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.017 | 0.079 | 0.05 | -0.025 | -0.003 |
| Dividends per Share |